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Abstract 
This study examined nutritional status and fecundity of women and was approved for patient 
enrollment by the ETSU Institutional Review Board (IRB). Once enrolled, participants filled 
out two food frequency questionnaires (FFQ, fruit/vegetable intake, fat intake), self-reported 
anthropometric data, and had one 5 mL vacutainer of whole blood (EDTA) collected for 
measures of oxidative stress (OS), coenzyme Q10 level, and fatty acid profile of the red blood 
cell (RBC) membrane. Participants were either designated to the case group (13 women 
experiencing fertility problems and an anti-mullerian hormone level of 1 ng/ml or less (AMH, 
<1 ng/mL)) or the control group (13 women experiencing normal ovulation cycles and no 
evidence of polycystic disease). This study hypothesized that the case group would have 
poorer plasma antioxidant status, consume more dietary saturated fat and have lower levels 
of omega-3 and higher levels of omega-6 fatty acids in the RBC membrane. Results showed 
that case participants had significantly higher body mass index (BMI) when graduating from 
high school, BMI upon enrollment in the study, and trended to gain more weight since high 
school. Antioxidant status of the plasma tended to be higher for the case group. This result 
was surprising as case participants consumed significantly fewer servings of fruits and 
vegetables (sources of antioxidants) than control subjects. FFQ results indicated that case 
participants consumed significantly higher amounts of total fat (g), saturated fat (g), 
unsaturated fat (g), and their diets had a higher dietary fat percent. No significant differences 
were noted in the individual fatty acids isolated from the RBC membrane or in calculated 
ratios of fatty acid between case and control groups. The fatty acid profile from RBC 
membranes are in agreement with self-reported fat intake from FFQ data and may provide a 
rationale for no differences observed between the two groups.  
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I.  Review of Literature 
Introduction 
Infertility is a problem affecting approximately 11 percent of the women of 
reproductive age in the United States (1). Generally speaking, infertility can be described as 
the inability to conceive after 12 or more months of unprotected sex. After that time period, 
investigation of issues regarding fertility is typically conducted. Assisted reproductive 
technology (ART) has become a viable treatment option for those trying to conceive and has 
been helping women become pregnant in the United States since 1981, most commonly 
through in vitro fertilization (1). The use of ART is still relatively rare; however over 1% of all 
infants born in the United States every year are conceived using this process based on the 
CDC’s 2011 ART Fertility Clinic Success Rates Report (1). The literature suggests that 
environmental and lifestyle factors play an important role in the effects of fertility including 
body weight. Although body weight is not a reliable predictor of conception among infertile 
women, there is evidence to suggest a negative correlation (2, 3, 4, 5, 6, 7). An increasing 
amount of research suggests that excessive amounts of oxidative stress may also play a 
significant role in fertility. Oxidative stress (OS) is caused by an imbalance between the 
formation of reactive oxygen species (ROS), such as free radicals and oxidants, and the body’s 
ability to neutralize them (8). OS, in turn, affects spermatozoa quality, endometriosis, 
fertilization rates, early embryo development and implantation and ultimately, pregnancy 
rates (8, 9, 10, 11, 12). Although ROS are naturally formed during many metabolic pathways, 
determining ways to counteract the build up of these reactive oxygen species has the potential 
to provide advantageous outcomes. Antioxidant intake and supplementation could provide 
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the answer in alleviating some of the problems regarding infertility through normalization of 
oxidative stress status (8, 13). 
 
ROS and OS 
Oxidative stress can occur when oxidants outnumber antioxidants, when products of 
peroxidation develop, and the pathological effects caused by these phenomena (10). OS is the 
consequence of the excessive production of reactive oxygen species and impaired defense by 
antioxidants (10). ROS are produced mainly by mitochondria and must be constantly 
inactivated to avoid excess formation in order to maintain normal cell function (10, 14). The 
main ROS molecules are generated as natural by-products of aerobic respiration and 
metabolism including the superoxide molecule (O2-), hydrogen peroxide (H2O2), hydroxyl 
radical (OH), and peroxynitrite (ONOO-) (15). Oxygen radicals target mitochondrial DNA due 
to its location near the inner mitochondrial membrane, which is where the majority of 
oxidants are formed (9). Another factor could be due to the lack of protective histone proteins 
within mitochondrial DNA (16). The ovaries, testes, and uterus are particularly affected by 
ROS because they contain the highest amount of mitochondria in the body due to the need for 
ATP, or energy, in those processes (17). Mitochondrial dysfunction can lead to a number of 
cellular consequences, which includes increased production of reactive oxygen species (18). 
Overproduction of ROS induces oxidative stress and can damage the cellular membrane, 
structure, and functions within mitochondria (14). Numerous clinical studies have shown that 
ROS may have roles in the female reproductive tract that are both physiological and 
pathological (8, 10, 11, 13). Evidence suggests that ROS production is increased when an 
upturn in mitochondrial ROS generation inhibits the release of calcium (Ca2+) and Ca2+-
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loading (14). Protecting the mitochondria against the oxidative damage of ROS is crucial for 
continued ATP production and prevention of cell death, or apoptosis (14). Disruption of the 
mitochondrial membranes from high levels of ROS can result in the release of cytochrome-C 
protein and thus activate apoptosis (10). Oxidative stress and endoplasmic reticulum (ER) 
stress can both result in cell death if left unresolved (19). While OS can affect several 
functions, ER stress essentially disturbs the folding of proteins on the ER (20).  
Furthermore, OS plays a critical role in the process of ovulation by inducing apoptosis 
of luteal cells within the ovary, which perturbs the area in and around ova and granulosa cells 
that could potentially decrease oocyte and embryo viability (21). However, repeated exposure 
of oxidative stress in the ova and other cells during ovulation suggests this might trigger 
ovarian aging (21). Polyunsaturated fatty acids (PUFAs), mainly docosahexaenoic (DHA), are 
important in biological membranes; however, they are the most vulnerable to attack from free 
radicals (14, 22). PUFAs also play important roles in mitochondrial Ca2+ homeostasis and 
function (14). PUFAs have a high degree of renewal in mitochondrial membranes and are a 
direct target of ROS, which makes them highly susceptible to peroxidation reaction (14). 
Peroxidation reactions that occur in mitochondrial membrane phospholipids can alter fluidity, 
permeability, and membrane function (14). ROS are generated by lipid peroxidation, which 
can alter mitochondrial function and increase reactive oxygen species (23). Lipid peroxidation 
can produce a considerable amount of ROS, however certain antioxidants are known to inhibit 
these events, such as catalase, superoxide dismutase, and glutathione peroxidase (24). 
Although originally regarded as cytotoxic, ROS molecules are considered important signaling 
molecules in several cell pathways (23). The peroxidation of omega-3 PUFAs by ROS can 
induce the formation of toxic products; therefore, dietary intake of these fatty acids could be 
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detrimental to cellular function (14). However, the cardiovascular and hemodynamic effects 
from consuming omega-3 PUFAs may counteract these effects. More research needs to be 
conducted on omega-3 fatty acid intake and supplementation in order to determine more 
conclusive results. 
Healthy individuals are able to maintain balance of ROS and antioxidants, however an 
imbalance of these reactive oxygen species can cause many problems. The generation of ROS 
and other oxidants are formed consequently through normal biological reactions (8). ROS can 
also be formed through external factors such as alcohol consumption, smoking, and 
environmental pollutants (8). Based on previous research, it is possible to infer that 
endometriosis and poor oocyte quality, among other problems affecting female reproduction, 
can occur due to excessive levels of these reactive oxygen species (25, 26, 27). Although more 
studies need to be conducted, some investigations have shown a correlation in the role of the 
imbalance of OS and the adverse effects of fertility including decreased oocyte quality and 
subsequent viability of embryos (9, 11, 21, 28, 29). 
Low levels of ROS play an important role in many processes including: normal 
reproductive function, intracellular messaging, apoptosis, immunity, and microorganism 
defense; however, the level at which ROS becomes degenerative requires further research (10, 
30). It is interesting to note that pregnancy itself may produce OS as a result of increasing 
tissue growth and catabolic activities (8). Increases in OS have been indicated in the formation 
of acute pregnancy complications or spontaneous abortion (8). Infertility can occur due to 
multiple reasons since successful pregnancies require numerous steps to occur such as 
ovulation of mature oocytes, proximity of sperm and oocyte in the reproductive tract, 
fertilization of the oocyte, and embryo development. The reasons for infertility may vary, 
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however, a significant correlation regarding the oxidative stress and fertility has been 
established and gained considerable interest in recent years.  
 
Problems surrounding OS and ROS 
An imbalance of OS in the follicular (FF) fluid environment of ovaries can cause 
detrimental issues, such as poor oocyte development, embryo development, and the overall 
outcome of pregnancy (9, 11, 12, 31). ROS can be produced in the FF environment, which 
contain oocytes, granulosa cells and surrounding cells, leukocytes, cytokines, and 
macrophages (11). Poor oocyte quality or increased risks of poor oocyte quality can be 
attributed to excessive OS production (9). Antioxidant enzymes, such as catalase, superoxide 
dismutase (SOD), and glutathione peroxidase (GPX), may inactivate ROS and help protect 
embryos and oocytes (19). Again, ROS and OS may occur due to an insufficient amount of 
these enzymes.  
Some researchers hypothesize that ovulated oocyte reduction and function could be 
the result of mitochondrial abnormality from repeated ovulation (21). One study analyzed the 
intracellular localization of mitochondria, which revealed that “the number of oocytes having 
heterogeneously localized mitochondria increased” considerably during repeated ovulation 
(21). Moreover, one of the biomarkers for OS, 8-OHdG (8-hydroxydeoxyguanosine), increased 
by repeated ovulation was inhibited by the administration of L-carnitine even though it lacks 
the ability to scavenge free radicals directly (21). L-carnitine has been shown to share a close 
resemblance to the properties of antioxidants, which can protect cells from oxidative damage 
and apoptosis (21). 
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 L-carnitine plays a crucial role in human metabolism, more specifically in the 
mitochondrial transport of long-chain free fatty acids (32). L-carnitine actively shuttles long-
chain fatty acids across the mitochondrial membrane for production of ATP and β-oxidation in 
tissues (32). ROS, as previously stated, are continuously produced under normal physiological 
conditions. Furthermore, they can easily initiate the peroxidation of membrane lipids and lead 
to the accumulation of lipid peroxides (32). Antioxidants can protect the human body from the 
effects of ROS and impede the progression of lipid peroxidation (32). The main enzymes in the 
antioxidant defense system include: superoxide dismutase, glutathione peroxidases, and 
catalase (32). L-carnitine may be able to protect these enzymes from further damage (32). 
According to a study comparing the antioxidant capacity of L-carnitine with α-tocopherol, a 
natural antioxidant, L-carnitine was proven an effective antioxidant (32). 
 
Preeclampsia 
 Oxidative stress is considered a key factor in the disease process of preeclampsia, 
which is the major cause of maternal morbidity and death afflicting approximately 3% to 5% 
of pregnancies (33, 34). Preeclampsia can be defined as the “new onset of hypertension and 
proteinuria (protein in urine) during the second half of pregnancy” (34). Overproduction of 
reactive oxygen species and synthesis of lipid peroxides may lead to maternal endothelial cell 
activation, which causes a proinflammatory response and is a hallmark of the disease (33). 
Antioxidant supplementation may be able to assist in the prevention or improvement of this 
disease (33). One randomized trial assessed the potential supplemental benefit of vitamin C 
and E in the prevention of preeclampsia, which was associated with reduced incidence of the 
disease and a reduction in the measure of endothelial and placental dysfunction (33). This 
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study’s results confirmed that antioxidant supplementation of vitamins C and E improved 
indicators of placental function oxidative stress in a group of low-risk women resulting in 
similar values as a group of healthy women (33). 
 Increased levels of circulating lipid peroxides is one of the consequences of decreased 
antioxidant activity (35). The synthesis of the endothelial cell-derived vasodilator prostacyclin 
is inhibited when lipid peroxide levels are elevated (35, 36). The disruption of platelet cell 
membranes is another action of peroxides resulting in the elevation of the prostaglandin, 
thromboxane (35, 36). An imbalance between thromboxane and prostacyclin is associated 
with this disease (36). The abnormal action of prostaglandins is one of the triggering factors 
of endothelial cell damage of certain diseases of pregnancy, such as preeclampsia (35). 
 
Endometriosis 
 Endometriosis is a common disorder characterized by the growth of endometrial cells 
outside the uterus (27). Patients with endometriosis may have worse outcomes with assisted 
reproduction techniques, such as in vitro fertilization (IVF) due to the lower quality of oocytes 
seen in these women (25). Lower oocyte quality is one of the many problems effecting women 
with infertility. The imbalance between ROS and the antioxidant defense system could be the 
possible cause of the resulting lower egg quality (25). ROS may “increase growth and adhesion 
of endometrial cells in the peritoneal cavity”, which could promote endometriosis and 
infertility (27). Two studies have found a positive correlation between oxidative stress and 
endometriosis (27, 37, 38). One study found that SOD, was significantly lower in infertile 
women with endometriosis suggesting that ROS could potentially play a role in the cause of 
infertility in these women (37). Another study viewed the autoantibodies of oxidative stress in 
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women and found that increased amounts of these autoantibodies were found in women with 
endometriosis, suggesting OS is occurring in women with endometriosis at an increasing rate 
(38). More research is required in order to find a significant correlation between 
endometriosis and infertility. 
Achieving greater antioxidant capacity in patients with endometriosis has shown 
promising results (25). In one experimental study, patients with endometriosis revealed 
lower levels of vitamin C in follicular fluid, which was most likely due to excessive 
consumption of antioxidants attempting to scavenge excess ROS (25). Moreover, researchers 
found significant correlations between “vitamin C levels and the number of oocytes retrieved, 
number of mature oocytes, and the number of fertilized oocytes” (25). Overall, these findings 
suggest that infertile women with endometriosis could have promising results if enhanced 
higher antioxidant capacity is achieved. 
 
In vitro fertilization (IVF) 
Despite advances in reproductive technology, the national success rate of IVF remains 
around 40% in most cases (39). Characteristics of in vitro fertilization success have been 
associated with the antioxidant capacity of FF during oocyte retrieval. A recent study of 
oxidative stress and oocyte quality in women undergoing IVF, using 8-OHdG as a biomarker 
for OS, indicated that 8-OHdG was considerably higher in the follicular fluid of women 
undergoing IVF and embryo transfer who showed high rate of degenerative oocytes compared 
to women with low rates of degenerative oocytes (9). Results from this study suggest that OS 
negatively impacts oocyte maturation and that supplementation of melatonin, vitamin E, or a 
combination of the two could improve oocyte quality and provide protection from OS (9). 
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Melatonin is a free radical scavenger that reduces oocyte DNA damage and α-tocopherol, the 
most abundant form of supplemented vitamin E, helps by maintaining homeostatic levels of 
ROS with evidence to suggest that it improves oocyte quality (9). The results also suggest a 
close relationship between oxidative stress and poor oocyte quality.  
During IVF, the follicular fluid removed from the ovary has provided insight in 
understanding the environment of the mature oocyte in infertility (8). One prospective study 
evaluated total antioxidant capacity (TAC) using follicular fluid collected from women 
undergoing oocyte retrieval for IVF (8, 13). Within the study, a lower baseline TAC was 
observed in the follicular fluid of the embryos that survived to the day of transfer (8, 13). 
There was an association found between successful fertilization and the higher FF total 
antioxidant capacity (8, 13). This study suggests that higher antioxidant status increases the 
probability of a successful conception using IVF. In contrast, another study measuring ROS 
and TAC in women undergoing IVF, found that of women who became pregnant, showed 
significantly higher FF ROS levels rather than those who did not become pregnant (8). Also, 
the TAC did not differ by pregnancy status in these women (8). This information was 
surprising; however, lack of reference values for healthy women was excluded in the 
comparison of this study population (8). These studies suggest that follicular fluid ROS may be 
a potential marker of IVF success and that higher TAC levels may predict higher fertilization 
potential (8). Follicular fluid containing high levels of antioxidants may help to control the 
generation of ROS and lipid peroxidation, resulting in improved fertilization rates (11).  
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Antioxidants 
 Oxidative stress can form through increased production of ROS or due to a deficiency 
of antioxidants (35). Antioxidants quench free radicals by donating an electron to the 
unpaired electron and becoming reduced (16). A deficiency of antioxidants could be due to 
decreased antioxidant intake, synthesis of antioxidant enzymes, or increased antioxidant 
utilization (35). In order to prevent the overproduction of reactive oxygen species, antioxidant 
enzymes provide a defense against ROS-induced oxidative damage (15). The main enzymes in 
the antioxidant defense system include: copper-zinc containing superoxide dismutase (Cu, Zn-
SOD or SOD1), manganese-containing SOD (Mn-SOD or SOD2), glutathione peroxidases (GPX) 
and catalase (CAT) (15). One of the central elements of cell signaling and maintenance of 
oxidation-reduction (redox) homeostasis is through the control of ROS by antioxidant 
enzymes (15). These enzymatic pathways are vital in processes of reproduction and 
development (15). Evidence suggests that the critical stages of gestation are implantation and 
early post-implantation since oxidative damage can have the most impact on the developing 
organism during those times (15). Therefore, antioxidant systems are essential against the 
protection of oxidative damage and cope with highly reactive and toxic free radicals (15).   
 The naturally occurring antioxidants protect cells from oxidation, which is essential as 
lipid peroxidation can cause DNA damage and directly inhibit certain proteins (30). Decreased 
antioxidant protection and increased lipid peroxidation generate epoxides, which may 
ultimately lead to cytotoxicity, allergy, mutagenicity, or carcinogenicity (30). Superoxide 
dismutase (SOD) is the antioxidant enzyme that catalyzes O2 into the less reactive H2O2, which 
can then be destroyed by CAT or GPX (30). Catalase (CAT) and glutathione (GPX) each play an 
important role in protecting cells against oxidative damage (30). Moreover, one of the most 
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essential antioxidant defense mechanisms is glutathione metabolism (30). The control of OS 
can be obtained by supplying known nutrients with antioxidant capabilities and minimizing 
substances that stimulate ROS (30). 
 
Antioxidants from the Diet 
In addition to antioxidant enzymes present in the human body, there are several 
beneficial dietary antioxidants including but not limited to: vitamin E, vitamin C, beta-
carotene, leutin, α-lipoic acid, coenzyme Q10, lycopene, and selenium (16). There is sufficient 
evidence to suggest that dietary antioxidants, including certain nutrients and cofactors, may 
impact oxidative stress and thus play a major role in female fertility (8, 40, 41). There are 
many proposed beneficial effects of antioxidants, folate, and flavonoids, including scavenging 
free radicals and ROS, which could potentially reduce inflammation and oxidative stress (40). 
Antioxidants such as vitamins C and E have shown to be helpful in reducing stress to ova, 
sperm, and reproductive organs (16, 41). Other nutrients shown to improve female 
reproduction and fertility include: vitamin B12, folic acid, magnesium, iron, and zinc (16, 41, 
42, 43, 44). Antioxidants scavenge molecules and work to convert ROS to water in order to 
prevent overproduction under normal conditions (29). One trial provided preconception 
multivitamins to females in couples trying to conceive, which indicated higher rates of 
conception among women receiving the multivitamin in comparison to women receiving trace 
elements or no supplementation (42). Another study reported that reduced antioxidant status 
increased the risk of spontaneous abortion (35). In these women, an imbalance was found 
between thromboxane and prostacyclin, which is associated with preeclampsia (35, 36). 
Wang et al. demonstrated that an imbalance between these prostaglandins was similarly 
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found in women with recurrent abortion (35, 36). Overall, sufficient nutrient supplementation 
should be a prerequisite of fertility for women trying to conceive and supplementation of 
vitamins and minerals may play an important role in optimizing fertility health. 
Several studies established that increased consumption of antioxidant-rich fruits and 
vegetables showed a negative correlation to oxidative stress, meaning that higher dietary 
antioxidant intake produced a lower occurrence of oxidative stress (24, 40). A diet that 
includes fruits and vegetables, which provides flavonoids and other antioxidants, has been 
associated with lower risk of oxidative stress in adults (40). One study involving adolescents 
showed that the beneficial effects of fruit and vegetable intake on oxidative stress are present 
by early adolescence and provide support for individuals to consume five or more servings 
per day to promote health (40). These results showed that increased consumption of fruits 
and vegetables have an effect on markers of inflammation and oxidative stress (40). For 
instance, lower concentrations of IL-6 (interleukin-6; cytokine that functions in inflammation) 
appeared when a greater amount of legumes and vegetables were consumed, while the 
vegetable group and TNF-α (tumor necrosis factor; inflammatory cytokine) were inversely 
related (40). These findings suggest that an ongoing pattern of increased consumption of 
fruits and vegetables could be beneficial throughout life in relation to oxidative stress (40). 
Another study focusing on the effects of increased vegetable and fruit consumption indicated 
significant reductions in markers of oxidative cellular damage to DNA and lipids by adherence 
to this type of diet (24). These studies help to confirm that a continual diet with high amounts 
of vegetables and fruits could result in several beneficial effects including decreased levels of 
ROS and free radicals, thus lowered oxidative stress. 
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Vitamin D 
Vitamin D has become a focus in recent years in regards to its roles in biological 
responses. The predominant source of vitamin D in humans occurs after the conversion of 7-
dehydrocholesterol by UV-B ray component of sunlight to produce pre-vitamin D3 (45). 
Nutritional forms of vitamin D consist of cholecalciferol (D3) and ergocalciferol (D2) (45). 
Vitamin D3 can be found in fatty fish and eggs whereas D2 is synthesized through the UV 
irradiation from yeast and fungi (45). A recent finding showed that, vitamin D receptor (VDR), 
is present in the ovary, uterus, placenta, and testis, which suggests that vitamin D may have a 
regulatory role in reproductive physiology; however, the vitamin may not be critical for 
successful reproduction (46). A recent study shows a reduction in anti-mullerian hormone 
with decreasing vitamin D levels, which indicates a possible role in ovarian reserve (47). More 
research is needed on the role of vitamin D in reproductive status and to determine if 
individuals with low serum levels (< 32 ng/mL, 25-OH-D3) have a higher frequency of 
reproductive difficulties (either male or female). 
 
Coenzyme Q10 (Ubiquiniol) 
 Coenzyme Q10 (CoQ10), or ubiquiniol, consists of a benzoquinone and a hydrophobic 
tail that contains isoprenoid units (16). CoQ10 can be reduced to ubisemiquinone (QH) and 
further reduced to ubiquinol (QH2). These reducing properties allow CoQ10 to function as an 
antioxidant or pro-oxidant depending on a number of factors, such as pH, or the presence of 
other redox couples including: vitamin E, vitamin C, and α-lipoic acid (16). It is possible that 
CoQ10 may become pro-oxidant (induce oxidative stress) if not given in conjunction with a 
redox couple previously stated (16). CoQ10 appears to play multiple roles in cells. The 
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functional roles of CoQ10 include: transferring electrons in the mitochondrial electron 
transport chain and functioning as an antioxidant in the inner mitochondrial membrane by 
inhibiting lipid peroxidation thus scavenging free radicals (48). CoQ10 is also the major source 
of superoxide and hydrogen peroxide generation (48). Coenzyme Q10 is mainly carried by 
lipoproteins in circulation where it is largely present in its reduced form as CoQ10H2 (49). 
CoQ10H2 has been shown as the first antioxidant depleted when low-density lipoprotein (LDL) 
undergoes in vitro oxidative stress (49). This also shows the possibility that CoQ10 could be a 
marker of oxidative stress or produce beneficial results if combined with other nutrient 
compounds. The antioxidant function of this enzyme may be significant to protect LDL from 
lipid peroxidation (49). The main role is considered the transfer of electrons through the 
electron transport chain and subsequent production of ATP, or energy (16).  
 Age is an important factor to consider when looking at reproductive potential. The 
peak age range of female fertility is 25 to 35 (50). Older patients trying to conceive may run 
into considerable difficulties. There are two main reasons for poor reproductive performance 
of older patients:  reduced ovarian reserve and increased risk of miscarriages and aneuploidy 
due to a higher rate of chromosomal aberrations (50). Reproductive changes in aging can lead 
to decreased ovarian reserve (50). One of the theories associated with decline in oocyte 
quality due to age is that highest-quality oocytes are selected first, which leaves unfavorable 
oocytes for later reproductive years (50). The second theory is that the process of aging 
produces unfavorable oocytes that remain in the ovary until possible selection in later years 
(50). The effects of aging are still widely unknown, however, one of the hallmarks of aging is 
the accumulation of mutations and deletions within mitochondrial DNA (50). Oocytes largely 
rely on ATP, or energy, produced by the mitochondria by oxidative phosphorylation (50). The 
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production of ROS is one of the byproducts of mitochondrial respiration, of which 90% is 
produced by the mitochondria (50). Increased amount of ROS has been correlated with the 
following factors: fatty acid oxidation, apoptosis, enzyme deficiencies, and reduced action of 
antioxidants (50). CoQ10 has shown promising results in the ability to normalize the 
bioenergetics status and oxidative balance in CoQ10 deficient patients in vitro (50). Therefore, 
there a possible correlation is present between CoQ10 status and decreased energy production 
seen in aging oocytes (50).  
Several studies involving the oral administration of CoQ10 show that it can act as a 
greater antioxidant against oxidative damage, especially in the mitochondria. In the rat, long-
term administration of CoQ10 caused a higher concentration CoQ10 in various tissues and their 
mitochondrial fraction, which suggests that supplementation of CoQ10 may be beneficial in 
lowering in vivo oxidative stress (48). Another study looking at the plasma concentration in 
patients with mitochondrial diseases revealed that the plasma concentration of CoQ10 was 
significantly higher after combination therapy of creatine, CoQ10, and lipoic acid (18). The 
results also discovered that lactate levels and measures of oxidative stress were reduced in 
these patients (16). In another study involving aged mice, treatment with CoQ10 increased the 
number of ovulated oocytes (51). Conversely, oocyte mitochondrial membrane potential 
(MMP) was reduced by CoQ10 supplementation while ROS levels increased as compared to 
similar levels in young oocytes (51). Overall, supplementation of CoQ10 in old mice appears to 
improve ovarian response and oocyte mitochondrial function (51). Although more studies 
need to be conducted, lone supplementation of CoQ10 may produce unexpected or inadequate 
results. However, combined with other compounds, increased plasma concentrations of CoQ10 
could be beneficial in mitochondrial function (16, 18). It is possible to surmise that the 
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production of ATP is crucial to the reproductive tract since the process of ovulation, 
developing an embryo, etc. are expensive in regards to energy. Therefore, the higher amount 
of plasma concentration of CoQ10 could produce positive outcomes in fertility and 
reproduction. 
 
Fatty Acid Intake and Fertility 
 Fertility can be adversely affected in many ways, however the effects of underweight 
and obesity have been shown to correlate negatively (2, 3, 4, 5, 6, 7, 19). Obesity is a major 
prevalence around the world and is a major risk factor in a number of chronic diseases, such 
as diabetes and heart disease (19). Polycystic ovarian syndrome (PCOS), which is one of the 
most common metabolic aberrations in women of reproductive age (52), can negatively affect 
fertility. PCOS and obesity have also shown a significant correlation to one another with 
obesity affecting 38-88% of women with PCOS (52). Several studies indicate that weight loss 
can improve or restore fertility among these women (52). 
Obesity is associated with “lipid accumulation in non-adipose tissue cells and the 
induction of oxidative stress”, which can be linked with systemic inflammation (19). Oxidative 
stress is one of the hallmark responses to intracellular lipid overload and is known to have 
detrimental effects in many tissues including the female reproductive tract (19). As adipose 
tissue expands in the body during obesity, its physiology drastically changes and initiates a 
chronic inflammatory response that influences the entire body (19). Oxidative stress is 
exhibited as “adipocytes undergo excessive hypertrophy” in order to store fat, and in turn, 
produce increased levels of cytokines or adipokines (19).  
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Female infertility is one of the neglected complications of obesity (19). The risk of 
infertility in obese women is almost three times as likely in comparison to nonobese women 
(3). Several factors are affected due to obesity besides infertility including: decreased 
conception rates and oocyte quality. Conception rates are considerably decreased by obesity 
even if the woman is experiencing normal menstrual cycles and in otherwise good health (19). 
With the rate of obesity at epidemic proportions, understanding the effects of obesity on the 
female reproductive system has become essential. Increased knowledge of obesity will help 
young women to alleviate the detrimental consequences on fertility (19).  
Anovulation, or a menstrual cycle without release of an oocyte, which is increased with 
obesity, may account for the delayed time to pregnancy (4, 19). Further studies show that 
obese women experiencing anovulation are less likely to be improved by treatment, such as 
clomiphene and gonadotropin hormones (53). Oocyte quality may be affected by obesity. 
Oocyte maturity was shown to be decreased in women with obesity in one of the studies with 
these evaluations (5, 19). Studies using mouse models were able to establish clearer results 
that concluded diet-induced obesity is harmful to oocytes (19). These mice models exhibited 
delayed maturation of oocytes, reduced rates of in vivo fertilization, and decreased oocyte 
development (6, 53). Thus, it can be concluded that obesity negatively impacts oocyte 
development and ovulation (6, 53). As previously stated, obesity is the “lipid accumulation in 
non-adipose tissue cells” and the ovary is not excluded from this response (19). In women, 
obesity can cause an increase in triglyceride levels in the follicular fluid that correlate with 
increased levels of free fatty acids and thus ROS (19).  
Lipotoxicity, or metabolic syndrome, results in oxidative stress and the production of 
ROS, which are damaging to cells because they can oxidize other proteins, such as LDL (19). 
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Oxidized LDL has recently become a marker of oxidative stress and has shown to be elevated 
in the serum and follicular fluid of obese women (19). Inflammatory ROS production can lead 
to the generation of H2O2, however, catalase and glutathione peroxidase enzymes can purge 
these oxidants (19). Increased levels of catalase and glutathione peroxidase enzymes have 
been seen in obese women suggesting an up-regulation of these antioxidant systems (19). One 
prospective study using mouse oocytes indicate that H2O2 is significantly harmful on the 
maturation of oocytes (9). However, another study observed a significant decrease in H2O2 
and the production of reactive oxygen species through supplementation with 6 g EPA 
(eicosapentaenoic acid) plus DHA per day (54). 
 
Omega-3 and Omega-6 Fatty Acids 
 Polyunsaturated fatty acids (PUFAs), which are fatty acids that contain more than one 
double bond, can be divided into various subcategories including: omega-3, omega-6, omega-
7, and omega-9 fatty acids, depending on the location of the first double bond (55). Several 
sources suggest that primitive human beings survived on a diet with a ratio of 1:1 omega-6 to 
omega-3 essential fatty acids (EFA) (56). The typical Western diet of the United States has 
shown a steady decline in the consumption of omega-3 EFA, with a ratio of omega-6 and 
omega-3 EFA as high as 20:1 (56). The significant increase in omega-6 fatty acid consumption 
along with a high omega-6 to omega-3 ratio in the Western diet has been shown to promote 
the pathogenesis of several diseases (e.g. cardiovascular disease, cancer, and certain 
inflammatory and autoimmune diseases) (56). The increased ratio of omega-6 to omega-3 
EFA may be, in part, due to decreased consumption of fish and the change in modern 
agriculture, which increased reliance on cereal grains. Common foods, such as fish, green leafy 
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vegetables, fruits, nuts, and berries, shaped pre-agricultural humans (56). The greater portion 
of our current food supply is highly dependent upon grains, which are high in carbohydrates 
and omega-6 EFA, but low in antioxidants and omega-3 EFA (56). Omega-3 polyunsaturated 
fatty acids are typically found in vegetable oils in the form of α-linolenic (ALA), or fatty fishes 
and marine food in the form of EPA and DHA (14, 57). Industrialized societies have reported 
an increase in energy intake, saturated fat, omega-6 EFA, trans-fatty acids, and cereal grains 
(56). In addition, these societies have reported a decrease in energy expenditure, omega-3 
EFA, complex carbohydrates, fiber, protein, antioxidants, and calcium intake (56). Modern 
agriculture may also serve as a factor in the increasing ratio of omega-6 to omega-3 EFA. 
Omega-3 fatty acids have decreased in animals, such as cattle, due to being fed a diet of grains 
as compared to their normal diet of plant life (56). The same reduction in omega-3 EFA can be 
seen in eggs, vegetable oil, cultivated vegetables, and cultivated fish (56). To ensure good 
health and normal development, one should strive for the balance of these essential fatty acids 
(56). Inflammation is influenced by the dietary intakes of both omega-3 and omega-6 PUFAs 
(58). Consumption of essential fatty acids, especially omega-3 EFA, are generally found to 
have favorable effects such as reduced risk of inflammation and chronic diseases.  
The predominant omega-6 PUFA in humans is linoleic acid (LA), which can be 
elongated and desaturated to arachidonic acid (AA) (55). AA is usually the major substrate for 
eicosanoid synthesis, which is a process involved in modulating the intensity and duration of 
inflammatory responses, and increases proinflammatory cytokine production (54, 58). 
Eicosanoids derived from AA are considered pro-inflammatory in comparison to those 
derived from omega-3 PUFAs, EPA, which curb the production of AA-derived eicosanoids (55, 
56, 58). Increased availability of long chain omega-3 fatty acids could potentially provide 
Oxidative Stress and Fertility 23
eicosanoid synthesis with more EPA and DHA than AA, thus reducing inflammation and 
certain diseases. The typical Western diet high in omega-6 EFA shifts the physiological state to 
pro-inflammatory and pro-thrombotic, which may increase the risk of chronic diseases such 
as coronary heart disease, atherosclerosis, and stroke (56). Research has shown that omega-3 
fatty acids could modify inflammatory and immune reactions and provide therapeutic effects 
against these inflammatory diseases (56). Therefore, higher levels of omega-3 PUFAs and 
lower omega-6 to omega-3 PUFA ratios have been associated with lower proinflammatory 
cytokine production (58).  
The increased ratio of omega-6 to omega-3 EFA in individuals who consume a Western 
diet also may potentially contribute to fertility problems (59). Recent research has 
emphasized the importance of consumption and supplementation of these essential fatty 
acids in pre- and postnatal outcomes in development (14). On the other hand, some 
researchers found that the dietary intake and increased content of omega-3 fatty acids may be 
detrimental to health due to the formation of toxic products caused by ROS-induced oxidative 
peroxidation of omega-3 EFA within membrane phospholipids (14). Exposure to dietary 
omega-3 fatty acids has been shown to disturb mitochondrial metabolism and reduce 
embryonic development in women in early pregnancy (14). This statement is consistent with 
the findings of a study involving the oocytes of adult female mice in order to determine how 
omega-3 PUFA supplementation might influence oocyte and pre-implantation embryo 
development (23). Evidence suggests that dietary omega-3 PUFA levels may alter the fatty 
acid composition of the oocyte, thus potentially impacting oocyte maturation and 
development (23). Several intracellular effects may occur due to high omega-3 consumption 
including: increased oxidative stress level and impaired embryo development (23). Overall, 
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additional research is needed in order to properly state the impact of omega-3 EFA intake and 
supplementation, especially in regards to pregnancy outcomes (14). 
 
Conclusion 
Infertility is a significant health problem that may be due, in part, to the adverse effects 
of oxidative stress and inflammation. Although ROS are naturally formed by mitochondria and 
during metabolic pathways, determining ways to counteract the build up of these free radicals 
could provide advantageous outcomes. The ovaries, testes, and uterus are particularly 
affected by ROS because they contain the highest amount of mitochondria in the body due to 
the need for ATP in those processes (17). Antioxidant intake and supplementation could 
propose alleviation of problems regarding infertility by normalizing oxidative stress status (8, 
13). Significant evidence has been compiled regarding the positive effects that the following 
nutrients have on multiple aspects of overall reproductive health: vitamin E, vitamin C, 
vitamin B12, beta-carotene, leutin, α-lipoic acid, coenzyme Q10, lycopene, selenium, folic acid, 
magnesium, iron, and zinc (16, 41, 42, 43, 44). Several factors are known to decrease fertility 
in women including body weight and decreased function of antioxidant enzymes. Intake of 
antioxidant nutrients, such as multivitamins or other therapeutic combinations, impacts the 
generation of ROS and may also play a beneficial role in female fertility. The assessment of OS 
through the use of laboratory techniques has helped to gain insight. The impact of the dietary 
fatty acid profile still needs further investigation; however, maintaining a diet that includes a 
lower ratio of omega-6 to omega-3 FA and more PUFAs should improve hemodynamics in 
patients. Ultimately, results from this research project could be helpful in developing 
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supplementation therapies to optimize probabilities related to successful pregnancy 
outcomes for at risk patients. 
 
II.  Materials and Methods 
Participant selection 
 The protocol for this study was reviewed and approved by the Institutional Review 
Board of East Tennessee State University’s Office of Research and Sponsored Programs. 
Participants in the case group were recruited from the Quillen Fertility and Women’s Services 
clinic and are the patients of Dr. Norman A. Assad, Associate Professor, OB/GYN. Females 
between the ages of 25 and 40 experiencing fertility difficulties, and with a low anti-mullerian 
hormone level (AMH, <1 ng/mL), served as the case group for this investigation. Exclusion 
criteria for the case group included women with polycystic ovarian syndrome. The control 
group also consisted of females between the ages of 25 and 40. Exclusion criteria for the 
control group included women experiencing irregular menstrual cycles and polycystic ovarian 
syndrome. A total of 60 patients will be recruited for this study with 30 women in each 
treatment group. The subject of this thesis included 26 patients; 13 women were recruited for 
the case group and 13 women for the control group. Participants filled out two food frequency 
questionnaires (FFQ, fruit and vegetable intake, fat intake), anthropometric data, and had one 
5 mL of whole blood (EDTA) collected for analysis of measures of oxidative stress, coenzyme 
Q10 level, and fatty acid profile of the red cell membrane. Participants understood they were 
under no obligation to participate in this trial. Participation in this research experiment was 
completely voluntary and participants could discontinue at any time.  
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 The following laboratory methods sections (Red blood cell (RBC) fatty acid profile, 
Isolation of RBC and lipid extraction, Analysis of fatty acids, and FRAP assay) were taken from 
an ETSU graduate thesis study (60). Due to the similarity of the laboratory methods used in 
both studies, permission was obtained to use the same procedures. Additionally, Ms. Litwin 
assisted in performing some of the blood sample analyses used for this research study. 
 
Self-reported patient anthropometric data 
Patients filled out information related to their anthropometric measurement including 
current body weight, body weight when graduating from high school, height, and current age. 
This data was used to calculate measures of body mass index (BMI) and weight gain since high 
school. 
 
Food Frequency Questionnaire 
 Each participant was prompted to fill out two food frequency questionnaires (FFQ) 
upon enrollment in this study. Block et al. (61) designed these instruments that have been 
validated through research and licensing was received for intended survey use. These food 
frequency surveys took approximately 5 minutes to complete and helped to provide a 
snapshot of the patient’s diet and offer a simple, inexpensive tool for researchers to assess 
(61). The meat/snacks survey, described as a brief fat screener, consisted of 15 items 
designed to assess dietary fat consumption in each patient (61). The fruit/vegetable/fiber 
survey consisted of 10 items designed to assess fruit and vegetable, fiber, and micronutrient 
intake in much less time than traditional food records or extensive FFQs (61). The food 
screener surveys were designed in comparison to the “gold standard” 1995 Block 100-item 
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Food Frequency Questionnaire (61). The gender and age of each patient were used as 
potential covariates in order to construct prediction equations using the food screener scores 
obtained from each patient (61). These equations were developed by Block et al. in order to 
compute point estimates of selected nutrients such as: total fat, saturated fat, percent fat, 
fruit/vegetable servings, vitamin C, magnesium, and potassium (61).  The equations were 
used to predict intake of the above-mentioned nutrient classes in this study. 
 
Prediction equations for Block Dietary Fat Screener (61): 
Total fat (gm) = 32.7 + [2.4 * (Meat/snack score)] + [11.2 * Sex] 
Saturated fat (gm) = 9.4 + [0.88 * (Meat/snack score)] – [3.5 * Sex] 
Percent fat = 19.8 + [0.6 * (Meat/snack score)] + [2.3 * Sex] 
 
Prediction equations for Block Fruit-Vegetable-Fiber Screener (61): 
Fruit/vegetable servings (Pyramid definition of servings per day) = -0.23 + [0.37 * 
(Fruit/vegetable score)] – [0.55 * Sex] 
Vitamin C (mg) = 56.5 + [6.6 * (Fruit/Veg/Beans score)] – [26.7 * Sex] – [0.45 * Age] 
Magnesium (mg) = 272 + [11.6 * (Fruit/Veg/Beans score)] – [92.3 * Sex] – [1.7 * Age] 
Potassium (mg) = 2348 + [114.8 * (Fruit/Veg/Beans score)] – [759 * Sex] – [13.8 * Age] 
Dietary fiber (gm) = 12.6 + [0.77 * (Fruit/Veg/Beans score)] – [5.12 * Sex] – [0.16 * Age] 
 
Laboratory Methods 
Red blood cell (RBC) fatty acid profile (60) 
 Blood samples were collected from trial participants into a 5-mL EDTA vacutainer and 
transported to the Human Nutrition and Dietetics Research Laboratory at the ETSU 
Valleybrook campus. Blood samples were processed within 48 hours after withdrawal to 
ensure validity. To analyze the blood, each sample was centrifuged at room temperature for 
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10 minutes at 4000 RPM. Once centrifuged, the resulting supernatant composed of plasma 
was decanted using a Pasteur pipette and transferred to a 3 mL glass amber vial. These vials 
were stored at  -30° C until further analysis for coenzyme Q10, vitamin D3, and antioxidant 
potential of the plasma (FRAP). The remaining sample was modified with equal parts normal 
saline (0.9% NaCl), vortexed briefly to disrupt the RBC pellet, and centrifuged for 5 minutes at 
4000 RPM. The clear supernatant layer was removed and discarded. This process was 
repeated two more times with the clear supernatant layer removed and discarded each time. 
 
Isolation of RBC and lipid extraction (60) 
  Kang and Wang (62) developed the procedure for lipid extraction and methylation of 
RBC, which was modified for use in this experiment. The final RBC pellet was put back into 
suspension in 25 μL of saline solution (0.9% NaCl) and vortexed. One-hundred μL of the RBC 
were extracted and transferred to clear, 150 mm screw-top test tubes with Teflon line caps. 
This step was performed twice due to duplicate samples run. Hexane (2 mL) (Fisher 
Scientific) and boron triflouride-methanol solution (2 mL) (BF3; Sigma-Aldrich) were added 
and vortexed in order to methylate the RBC samples. In a heating block, the mixture was 
heated for one hour at 100°C in order to generate fatty acid methyl esters (FAME). The 
solution was allowed to cool to room temperature. Deionized distilled water (1.5 mL) (DDW) 
was added, vortexed briefly, and centrifuged for 1 minute at 4000 RPM. The hexane layer was 
removed and added to a new, 150 mm screw-top test tube, and dried in a heated water bath at 
50° C. Once evaporated, FAME were put back into suspension with 275 μL of hexane and 
transferred to a 1.5 mL amber glass autosampler vial. These vials were equipped with a low 
volume insert (300 μL) (Fisher Scientific) and with an internal standard (5 μL, C-17 fatty acid, 
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Nu-Chek Prep, Inc.) added to validate FAME time signatures for peak integration. Samples 
were stored at -30° C until analysis by gas chromatography. 
 
Analysis of fatty acids (60) 
Flame ionization gas chromatography (GC) (Shimadzu) was used for analyzing FAME 
using a capillary column (Phenomenex, Zebron ZB-WAX). The column conditions necessary 
for analysis included the following: helium as a carrier gas with a flow rate of 30 mL/min and 
a temperature program of a constant temperature ramp (2° C/minute) between hold 
temperatures. The temperature was held for 5 minutes at an initial temperature of 160° C; 
then held for 8 minutes, 10 minutes, 15 minutes, 15 minutes, and 20 minutes at increasing 
increments of 10° C per hold time from the initial temperature. The total run time for each 
sample in the GC was 100 minutes. Additional instrument conditions included: autosampler 
injection of 1 μL; flame ionization detector (FID) temperature of 255° C; injector port 
temperature of 250° C; hydrogen flow rate of 40 mL/min; and air flow rate of 400 
mL/min1q1’q. Using comparison of known standards, individual peaks were identified and 
individual fatty acids were measured as a percent of total area under the peak.  
 
FRAP Assay (60) 
The plasma was evaluated for antioxidant capacity using a spectrophotometric 
technique:  ferric reducing ability of plasma (FRAP) assay as described and modified by 
Benzie and Strain (63). FRAP assay is used to determine total antioxidant capacity in serum 
samples. The FRAP reagent was prepared fresh before each series of measurements to ensure 
validity. The reagent contained the following materials:  200 mL of acetate buffer (300mM, pH 
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3.6), 20 mL TPTZ solution (0.062 g 2,4,6-tripyridyl-s-triazine, or TPTZ, in 20 mL 40mM HCl), 
20 mL FeCl3 solution (0.2748 g FeCl3-6H2O in 50 mL DDW), and 24 mL DDW. Samples were 
run in triplicate with 20 μL of serum added to 60 μL of DDW and 1000 μL of FRAP reagent, 
briefly vortexed, and incubated for 4 minutes at room temperature. The absorbance (592 nm) 
was determined against a blank vial consisting of 1000 μL of FRAP reagent and 80 μL of DDW. 
The standard curve was calibrated using a series of standards from diluting 1 mM ferrous 
sulphate solution. The concentration for the series of dilutions included: 0.1, 0.2, 0.4 at 
increasing increments until the concentration reached 1.0 mM. FRAP values were determined 
by UV-visible spectrophotometer. 
 
Coenzyme Q10 
 The plasma will be evaluated for total Coenzyme Q10 (CoQ10) using an assay developed 
by Mosca et al. (64) and modified by W. A. Clark and R. M. Mohseni (personnel 
communication). Plasma (200 μL) was mixed with 50-μL of 1, 4-benzoquinone solution (2 
mg/mL ethanol) and vortexed for 10 seconds. The solution was allowed to incubate for 10 
minutes at room temperature. Normal propanol (1 mL, Fisher Scientific) was added to the 
mixture, briefly vortexed and centrifuged for 9 minutes at 4000 RPM. The supernatant was 
decanted with a Pasteur pipette, transferred to a 3 mL amber vial and stored at -30°C until 
further analysis. Analysis of plasma CoQ10 levels will be completed via high-pressure liquid 
chromatography with mass spectroscopy using a technique developed by R. M. Mohseni 
(personnel communication). This analysis will not be completed until all 60 samples have 
been collected and only the methodology for sample preparation is the subject of this thesis. 
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Statistical analysis 
 Mean values and standard deviations were calculated for FRAP, RBC fatty acid profile, 
RBC fatty acid ratios, and data derived from FFQ surveys and self-reported anthropometric 
data. Data was analyzed using general linear models program in SPSS version 20 (IBM Corp., 
Armonk, NY, USA). Case status was identified as the independent variable (case vs. control 
patients) while data from laboratory analysis and surveys were used in a univariate model as 
dependent variables. No covariates were used in any analysis. Differences between the values 
were considered significant if the P-values were ≤ 0.05. 
 
III. Results 
Participants 
Twenty-six participants fulfilling the inclusion criteria were included in this study. 
Participants wanting to be included in the study signed informed consent documents 
developed through the IRB approval process. Once enrolled in the trial, all 26 participants 
filled out a questionnaire related to anthropometric measures, two food frequency 
questionnaires (FFQ, fruit and vegetable intake, fat intake) and consented to a blood draw.  
Two groups were formed according to whether the participants’ were fertility patients of Dr. 
Norman Assad (Quillen Fertility and Women’s Services) or control patients otherwise 
experiencing normal ovulation cycles and no evidence of polycystic disease. The case group 
consisted of 13 women experiencing problems with fertility and having an anti-mullerian 
hormone level of 1 ng/ml or less (AMH, <1 ng/mL). The mean age of the participants was 28.7 
± 1.1 years for the control group and 34.5 ± 0.9 years for the case group as shown in Table 1. 
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All of the participants were women and were not experiencing issues with polycystic ovarian 
syndrome. Race and ethnicity were not determining factors for this thesis.   
Descriptive statistics pertaining to the participants from basic information acquired 
from each participant is shown in Table 1.  Participants in the case group (fertility patients) 
had significantly higher age at enrollment in the study, body mass index (BMI) when 
graduating from high school (self-reported), BMI at enrollment in the study (self-reported), 
and weight gain since high school was approaching significance (P=0.081). The average BMI 
(current) of the control group was 22.9 ± 3.89 and 29.9 ± 10.34 for the case group. Based on 
BMI value, the case group was borderline obese, but still considered to be overweight 
(Overweight: 25.0-29.9) (65). The control group, on the other hand, was considered to be at a 
healthy weight (65). As noted in Table 1, participants from the control and case group were 
considered to be at a healthy weight in high school, however the control group was 
significantly (P=0.03) lighter.   
 
Table 1: Self-reported anthropometric data of participants reported as mean ± std and classified 
as case or control with the corresponding value of significance. Where (n) equals the number of 
participants per group. 
Variable Control mean ± std, n=13 Case mean ± std, n=13 P-value 
Age (years) 28.7 ± 4.13 34.5 ± 3.48 0.001 
Wt. gain since high school 
(lbs.) 
16.5 ± 17.11 37.38 ± 37.60 0.081 
High School BMI (kg/m
2
)  20.2 ± 2.88 23.5 ± 4.43 0.030 
Current BMI (kg/m
2
) 22.9 ± 3.89 29.9 ± 10.34 0.030 
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Measures of Oxidative Stress 
A total of 26 FRAP assays (13 per group) were conducted and included in the analysis 
for this study as noted in Table 2 and Graph 1. The average concentration of FRAP values for 
the case group (n=13) was 0.384 ± 0.111 μmol/L, while the average FRAP value for the 
control group (n=13) was 0.329 ± 0.052 μmol/L (mean ± std). Although the difference 
between the two groups was not considered significant, the level was approaching 
significance (P=0.12). Most of the participants in the case group had higher mean FRAP 
concentrations when compared to control participants. The higher antioxidant assay of the 
plasma was surprising especially since the control group participants were shown to consume 
more antioxidants as seen in the results of the food frequency questionnaires.  
Plasma from this study will be evaluated for CoQ10 concentration and this information, 
in addition to the FRAP analysis, may be useful in assessing the true antioxidant status of the 
participants in this study. However, analysis of CoQ10 levels in the plasma will not be 
completed until all 60 samples have been collected and only the methodology for sample 
preparation is the subject of this thesis. Once all samples have been collected, analysis of 
plasma CoQ10 levels will be evaluated via high-pressure liquid chromatography with mass 
spectroscopy using a technique developed by R. M. Mohseni (personnel communication). 
 
Table 2: Analysis from FRAP Assays reported as mean ± std and classified as case or control with 
the corresponding value of significance. Where (n) equals the number of participants per group. 
  Control mean ± std, n=13 Case mean ± std, n=13 P-value 
FRAP Assay 0.329 ± 0.052 μmol/L 0.384 ± 0.111 μmol/L 0.120 
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Graph 1: Average FRAP value by case and control status. Values are reported as mean ± std. 
 
 
Responses to Food Frequency Questionnaire 
Descriptive statistics pertaining to the food frequency questionnaires are found in 
Table 3. The data is derived from prediction equations gleaned from the answers reported in 
the FFQs. Prediction equations were developed by Block et al. and are validated as reported in 
the rapid food screener study (61). Two separate FFQs were used in this study: dietary fat 
survey and dietary fruit-vegetable-fiber survey. The mean results of the FFQs revealed that 
case participants consumed significantly higher nutrients in each of the following categories: 
total fat (g), saturated fat (g), unsaturated fat (g), and percent fat. The average total fat 
consumption reported for the control group was 85.8 ± 12.80 g and 96.9 ± 16.67 g for the case 
group; these values were approaching significance (P=0.069). The average saturated fat 
consumption reported for the control group was 22.0 ± 6.61 g and 25.4 ± 6.11 g for the case 
group; however, these values were considered insignificant (P=0.197). The average 
unsaturated fat consumption reported for the control group was 63.8 ± 7.02 g and 71.5 ± 
10.56 g for the case group; these values were considered significant (P=0.037). Unsaturated 
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fat consumption was calculated by subtracting the saturated fat (g) from the total fat (g) as 
determined by the prediction equations in the FFQ. The average percent fat reported for the 
control group diet was 32.6 ± 3.19% and 35.3 ± 4.17% for the case group; these values were 
approaching significance (P=0.071).  
The responses from the fruit and vegetable questionnaire revealed that control 
participants consumed approximately 68% more servings of fruits and vegetables than the 
case group, which was 4.2 ± 1.55 and 2.9 ± 1.04 servings per day, respectively (P=0.019). 
These results were consistent with the higher amount of consumed nutrients calculated by 
the fruit and vegetable FFQ as seen in control participants noted in Table 3. The average 
vitamin C (mg) reported for the control group was 143.4 ± 51.15 mg and 99.6 ± 27.45 mg for 
the case group; these values were considered significant (P=0.012). The average magnesium 
(mg) reported for the control group was 353.0 ± 90.40 mg and 270.9 ± 48.27 mg for the case 
group; these values were considered significant (P=0.008). The average dietary fiber (g) 
reported for the control group was 17.7 ± 6.06 g and 11.9 ± 3.21 g for the case group; these 
values were also considered significant (P=0.006). Finally, the average potassium (mg) 
reported for the control group was 3113.9 ± 1195.39 mg and 2595.9 ± 477.41 mg for the case 
group; however, these values were considered insignificant (P=0.160).   
 Data was also developed for saturated fat (g) and unsaturated fat (g) as a percent of 
total fat (g) and the ratio between the two. The average saturated fat as a percent of total fat 
was 25.3 ± 3.72 for the control group and 25.9 ± 1.91 for the case group (P=0.601). The 
average unsaturated fat as a percent of total fat was 74.4 ± 3.72 for the control group and 74.1 
± 1.91 for the case group (P=0.601). Finally, the ratio of saturated to unsaturated fat, as a 
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percent of the total fats, was reported for the control group as 0.34 ± 0.74 and 0.35 ± 0.36 for 
the case group (P=0.641). 
 
Table 3: Data from Food Frequency Questionnaires with the corresponding value of significance 
for each variable. Where (n) equals the number of participants per group. 
Variable Control mean ± std, n=13 Case mean ± std, n=13 P-value 
Total fat (g/day) 85.8 ± 12.80 96.9 ± 16.67 0.069 
Saturated fat (g/day)  22.0 ± 6.61 25.4 ± 6.11 0.197 
Unsaturated fat (g/day) 63.8 ± 7.02 71.5 ± 10.56 0.037 
Percent Dietary fat (%) 32.6 ± 3.19 35.3 ± 4.17 0.071 
  Saturated fat (% of total fat) 25.3 ± 3.72 25.9 ± 1.91 0.601 
 Unsaturated fat (% of total fat) 74.4 ± 3.72 74.1 ± 1.91 0.601 
Saturated: Unsaturated 
calculated ratio 0.34 ± 0.74 0.35 ± 0.36 
 
0.641 
Fruit/Vegetable (servings/day) 4.2 ± 1.55 2.9 ± 1.04 0.019 
Vitamin C (mg/day) 143.3 ± 51.15 99.6 ± 27.45 0.012 
Magnesium (mg/day) 353.0 ± 90.40 270.9 ± 48.27 0.008 
Potassium (mg/day) 3113.9 ± 1195.39 2595.9 ± 477.41 0.160 
Dietary Fiber (g/day) 17.7 ± 6.06 11.9 ± 3.21 0.006 
 
Analysis of RBC Fatty Acid Composition 
Fatty acid composition of red blood cells for case and control patients is displayed in 
Table 4 and Table 5 regarding the results of individual fatty acid profiles as well as correlated 
ratios of average saturated FA, average unsaturated FA, monounsaturated fatty acids 
(MUFAs), and polyunsaturated fatty acids (PUFAs). This research study hypothesized that the 
case group would consume more saturated fat, have lower levels of omega-3 fatty acids, 
higher levels of omega-6 fatty acids, and have a higher saturated to unsaturated fatty acid 
ratio.  Results from the analysis of the red blood cell membrane fatty acid profile do not 
support this hypothesis. The average omega-6 fatty acids reported from the control group was 
13.67 ± 2.42 and 14.20 ± 2.65 for the case group (P=0.600) while the average omega-3 fatty 
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acids reported from the control group was 2.28 ± 0.67 and 1.52 ± 1.35 for the case group 
(P=0.426). The average fatty acids of total saturated fat reported from the control group were 
18.77 ± 4.17 and 18.81 ± 4.19 for the case group (P=0.979). However, the data did show some 
numerical trends consistent with expected results. The control group consumed less omega-6 
fatty acids, higher amounts of omega-3 fatty acids, and lower amounts of total saturated fatty 
acids. The patient population included in this study is less than half of the complete study 
population and final results still need to be evaluated once the research trial completes 
patient enrollment. 
 
 
Table 4: Analysis of Individual Fatty acid profiles of RBC membranes for cases and controls. Fatty 
acids are expressed by average % area under the peak and reported as mean ± std; n. Where (n) 
equals the number of participants. 
Fatty Acid, omega type, 
carbon:double bonds Control mean ± std, n Case mean ± std, n P-value 
Myristic, 16:0 1.43 ± 0.52, 8 1.32 ± 0.83, 8 0.764 
Palmitic, 16:0 26.56 ± 2.24, 13 25.75 ± 2.44, 13 0.385 
Palmitoleic (n-7), 16:1 2.08 ± 0.65, 12 2.49 ± 0.90, 11 0.224 
Stearic, 18:0 21.34 ± 1.75, 13 21.65 ± 1.13, 13 0.588 
Oleic (n-9), 18:1 13.72 ± 1.36, 13 13.76 ± 0.92, 13 0.928 
Linoleic (n-6), 18:2 13.79 ± 1.51, 13 13.51 ± 1.63, 13 0.655 
Arachidonic (n-6), 20:4 19.62 ± 1.65, 13 19.99 ± 2.47, 13 0.655 
EPA (n-3), 20:5 n=0 1.05, 1 n/a 
Adrenic(n-6), 22:4 2.09 ± 1.13, 8 2.94 ± 1.58, 7 0.252 
DPA (n-3), 22:5  n=0 0.94, 1 n/a 
Lignoceric, 24:0 n=0 1.76, 1 n/a 
DHA (n-3), 22:6 2.28 ± 0.67, 3 3.55 ± 0.95, 2 0.171 
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Table 5: Analysis of Fatty Acid Ratios. Fatty acids are expressed by average % area under the 
peak and reported as mean ± std; n. Where (n) equals the number of participants. 
Fatty Acid Types & Ratios (% 
area under chromatogram curve) Control mean ± std, n Case mean ± std, n P-value 
Average Omega-6  13.67 ± 2.42, 13 14.20 ± 2.65, 13 0.600 
Average Omega-3  2.28 ± 0.67, 3  1.52 ± 1.35, 3 0.426 
Omega-6:Omega-3 Ratio  5.35 ± 1.71, 3 5.43 ± 1.31, 2 0.959 
MUFA: PUFA 0.45 ± 0.06, 13 0.45 ± 0.06, 13 0.984 
Total Saturated FA 18.77 ± 4.17, 13 18.81 ± 4.19, 13 0.979 
Total Unsaturated FA 10.99 ± 1.89, 13 11.33 ± 1.85, 13 0.643 
Saturated: Unsaturated Ratio 1.72 ± 0.32, 13 1.67 ± 0.32, 13 0.715 
 
IV. Discussion 
Participants 
The aim of our study was to explore the possible relationship between oxidative stress 
and the fecundity of women. Therefore, in order to form an accurate comparison between 
oxidative stress (OS) and fertility, case participants consisted of fertility patients of Dr. 
Norman Assad between the ages of 25 and 40 with a low anti-mullerian hormone level (AMH, 
<1 ng/mL) experiencing fertility difficulties. Control patients were compared to the case 
participants, which consisted of women ages 25 to 40. Exclusion criteria for controls were 
women experiencing irregular menstrual cycles and the presence of polycystic ovarian 
syndrome. The subject for this thesis includes 26 patients; 13 women were recruited for the 
case group and 13 women for the control group. Participants understood that this research 
was completely voluntary and could discontinue at any time. No participants opted out of the 
trial or were excluded from the data. The mean age of the participants was 28.7 ± 4.13 years 
for the control group and 34.5 ± 3.48 years for the case group as shown in Table 1.  
Participants in the case group (fertility patients) had significantly higher age upon 
enrollment in the study, which could be an overall factor in fertility. The peak age range for 
Oxidative Stress and Fertility 39
female fertility is 25 to 35 years (50). One of the theories that explains why older patients 
experience poor reproductive performance is the decline in oocyte quality (50). This theory 
goes on to explain that the highest-quality oocytes are selected first, leaving less favorable 
oocytes to be selected in later reproductive years (50). The effects of aging are still widely 
unknown, however the accumulation of cellular mutations and deletions within mitochondrial 
DNA has been noted (50). Our results indicate that the volunteers who met the age restriction 
criteria and enrolled in the research trial as control patients are significantly younger than the 
case group experiencing infertility. Age in our test population may be a factor in the case 
groups’ reduced reproductive potential and explain why the women undergoing fertility 
treatments are older. 
Participants in the case group reported significantly higher body mass index (BMI) 
when graduating from high school (P=0.03), BMI upon enrollment in the study (P=0.03), and 
weight gain since high school approached significance (P=0.081). The average BMI (current) 
of the control group was 22.9 ± 3.89 and 29.9 ± 10.34 for the case group. Based on BMI value, 
the case group was borderline obese, but still considered to be overweight (Overweight: 25.0-
29.9) (65). As noted in Table 1, participants from the control and case group were considered 
to be at a healthy weight in high school; however, the control group was significantly lighter 
(p=0.03). Weight may be considered another significant factor in infertility. The effects of 
obesity have been shown to correlate adversely with fertility and may be one of the neglected 
complications of infertility (2, 3, 4, 5, 6, 7, 19). Anovulation, or a menstrual cycle without 
release of an oocyte, which is increased with obesity, may account for the delayed time in 
pregnancy (4, 19). Studies using mouse models were able to establish clearer results that 
concluded in showing that diet-induced obesity is harmful to oocytes (19). These mice models 
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exhibited delayed maturation, reduced rates of in vivo fertilization, and decreased oocyte 
development (6, 53). Thus, it can be concluded that obesity negatively impacts oocyte 
development and ovulation (6, 53). The risk of infertility in obese women is almost three 
times as likely in comparison to non-obese women (3), which is consistent with the 
participant results seen in this study.  
 
Measures of Oxidative Stress 
 Ferric reducing antioxidant power (FRAP) assays were conducted on each of the 
participants and included in the analysis of this study. Results from the FRAP assays are noted 
in Table 2 and Graph 1. Surprisingly, the ferric reducing ability of the plasma in case group 
participants was found to have a numerically higher antioxidant capacity (P=0.12) as 
compared to participants in the control group. The average concentration of FRAP values for 
the case group (n=13) was 0.384 ± 0.111 μmol/L, while the average FRAP value for the 
control group (n=13) was 0.329 ± 0.052 μmol/L (mean ± std).  A possible explanation to this 
result could be due to the case group participants’ antioxidant defense system being in a 
hyperactive state in order to compensate for the amount of oxidative stress within the body. 
This result is consistent with other models comparing the antioxidant capacity of dogs with 
cardiac disorders and that of controls (66, 67). Researchers from these studies found 
increased levels of plasma antioxidants (FRAP) in dogs with heart disease and other cardiac 
problems (66, 67). The researchers from these studies found a possible explanation to be 
increased uric acid levels, which could increase FRAP levels (66). Uric acid or other 
compensatory mechanisms may be contributing to increased antioxidant level exhibited by 
the case group. Levels of uric acid were not measured in this research trial. The differences 
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between the antioxidant levels of the groups in this study did not reach significance (P=0.12), 
however, these results may become more significant once all participants are recruited for 
this study. Additional assays of antioxidant capacity should be considered in order to 
determine if uric acid was a factor in this measure of antioxidant potential. 
 
Food Frequency Questionnaires 
Within the data self-reported by participants, which includes the responses from the 
food frequency questionnaires, several variables were evaluated and showed a significant 
difference between control and case groups. These variables can be found in Table 3. Results 
of the FFQs revealed that case participants consumed significantly higher amounts of: total fat 
(g), saturated fat (g), unsaturated fat (g), and their diets had a higher dietary fat percent.  The 
average total fat consumption reported for the control group was 85.8 ± 12.80 g and 96.9 ± 
16.67g for the case group; these values were approaching significance (P=0.069). Data was 
also developed for saturated fat and unsaturated fat as a percent of total fat consumed and the 
ratio between the two (Saturated:Unsaturated). The average saturated fat as a percent of total 
fat was 25.3 ± 3.72 % for the control group and 25.9 ± 1.91% for the case group (P=0.601). 
The average unsaturated fat as a percent of total fat was 74.4 ± 3.72 % for the control group 
and 74.1 ± 1.91 % for the case group (P=0.601). Finally, the ratio of saturated to unsaturated 
fat, as a percent of the total fats, was reported for the control group as 0.34 ± 0.74 and 0.35 ± 
0.36 for the case group (P=0.641). These results were consistent with the red blood cell 
membrane fatty acid, which can be found in Table 5. 
The fruit and vegetable FFQ revealed that control participants consumed 
approximately 68% more servings of fruits and vegetables than the case group, which was 4.2 
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± 1.55 and 2.9 ± 1.04 servings per day, respectively (P=0.027). The higher fruit and vegetable 
consumption by the control group is reflected in the nutrient analysis. There is sufficient 
evidence to suggest that dietary antioxidants, including vitamins, minerals, and specific 
cofactors may impact oxidative stress and thus play a major role female fertility (8, 40, 41). 
There are many proposed beneficial effects of antioxidants, folate, and flavonoids, including 
scavenging free radicals and ROS, which could potentially reduce inflammation and oxidative 
stress (40). Antioxidants such as vitamins C and E have shown to be helpful in reducing stress 
to ova, sperm, and reproductive organs (16, 41). Other nutrients shown to improve female 
reproduction and fertility include: vitamin B12, folic acid, vitamin E, magnesium, selenium, 
iron, and zinc (16, 41, 42, 43, 44).  
 
Analysis of RBC Fatty Acid Profile 
Fatty acid composition of red blood cell membranes for case and control patients is 
found in Table 4 and Table 5. Results of individual fatty acid profiles as well as correlated 
ratios of average saturated FA, average unsaturated FA, MUFAs, and PUFAs are indicated in 
these tables. This research study hypothesized that the case group would consume more 
saturated fat, have lower levels of omega-3 fatty acids, higher levels of omega-6 fatty acids, 
and have a higher saturated to unsaturated fatty acid ratio. However, results from the analysis 
of the red blood cell membrane fatty acid profile did not support this hypothesis. The average 
omega-6 fatty acids reported from the control group was 13.67 ± 2.42 and 14.20 ± 2.65 for the 
case group (P=0.600) while the average omega-3 fatty acids reported from the control group 
was 2.28 ± 0.67 and 1.52 ± 1.35 for the case group (P=0.426). The ratio of omega-6 to omega-3 
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fatty acids was calculated at 5.35 ± 1.71 for the control group and 5.43 ± 1.31 for the case 
group (P=0.959).  
The predominant omega-6 PUFA in humans is linoleic acid (LA), which can be 
elongated and desaturated to arachidonic acid (AA) (55). AA is usually the major substrate for 
eicosanoid synthesis, which is a process involved in modulating the intensity and duration of 
inflammatory responses, and increases proinflammatory cytokine production (54, 58). 
Eicosanoids derived from AA are considered pro-inflammatory in comparison to those 
derived from omega-3 PUFAs, EPA, which curb the production of AA-derived eicosanoids (55, 
58). Increased availability of long chain omega-3 fatty acids could potentially provide 
eicosanoid synthesis derived from EPA and DHA than AA, thus reducing inflammation and 
certain diseases. Therefore, higher levels of omega-3 PUFAs and lower omega-6 to omega-3 
PUFA ratios have been associated with lower proinflammatory cytokine production (58). The 
increased ratio of omega-6 to omega-3 EFA in individuals who consume a Western diet also 
may potentially contribute to fertility problems (59). Recent research has emphasized the 
importance of consumption and supplementation of these essential fatty acids in pre- and 
postnatal outcomes in development (14).  
On the other hand, some researchers found that the dietary intake and increased 
content of omega-3 fatty acids may be detrimental to health due to the formation of toxic 
products caused by ROS-induced oxidative peroxidation of omega-3 EFA within membrane 
phospholipids (14). Exposure to dietary omega-3 fatty acids has been shown to disturb 
mitochondrial metabolism and reduce embryonic development in women in early pregnancy 
(14). This statement is consistent with the findings of a study involving the oocytes of adult 
female mice in order to determine how omega-3 PUFA supplementation might influence 
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oocyte and pre-implantation embryo development (23). Evidence suggests that dietary 
omega-3 PUFA levels may alter the fatty acid composition of the oocyte, thus potentially 
impacting oocyte maturation and development (23). 
Although the ratio of omega-6 to omega-3 was found to be higher in the case group 
versus the control group, the data was not statistically significant (P=0.959). The data was 
able to show some numerical trends consistent with expected results, however. The control 
group consumed higher amounts of omega-3 fatty acids (FA), lower amounts of omega-6 FA, 
and lower total saturated fatty acids. The statistical insignificance of omega-6 to omega-3 FA 
shown could be attributed to the insignificant amount of omega-3 FA analyzed from each 
participant’s fatty acid profile; only 5 participants had omega-3 FA in the RBC. Further 
interpretation may be possible once all 60 participants have been recruited and complete the 
study.  
Conclusion 
In the summer of 2014, all sixty trial participants will have been evaluated and 
analyzed for their antioxidant capacity, complete fatty acid profile including ratios of omega-6 
to omega-3 and saturated to unsaturated fatty acids, levels of coenzyme Q10, along with the 
FFQs for each subject. This thesis consists of only preliminary data, as the study will not 
conclude until a total of 60 patients have been recruited and meet the inclusion requirements. 
The complete trial should supply more conclusive and significant results regarding each 
variable. This project has been designed to test the hypothesis that women undergoing more 
oxidative stress are more likely to have problems with fertility. The results of the conclusion 
of the trial may be able to indicate whether the proposed hypothesis is correct; however, the 
initial results are still inconclusive at this time.  
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